Despite the fact that MARCO has already been found to be a marker for pro‐tumorigenic TAMs in NSCLC,[45] breast cancer,[52] and GBM,[44] its role in RCC has not been thoroughly documented previously. This evidence concerns the gene MARCO and breast cancer.